Literature DB >> 10363404

Clinical and laboratory evolution of a culture-confirmed case of human granulocytic ehrlichiosis.

D Hossain1, M E Aguero-Rosenfeld, H W Horowitz, J M Wu, T C Hsieh, N Sachdeva, S J Peterson, J S Dumler, G P Wormser.   

Abstract

A 74-year-old man from suburban New York City, who was hospitalized because of chest pain and fever, was diagnosed as having human granulocytic ehrlichiosis on the eighth hospital day. Although leukocyte and platelet counts were normal on admission, they fell to abnormally low values then normalized prior to specific therapy against the human granulocytic ehrlichiosis agent. Intracytoplasmic inclusions suggestive of Ehrlichia were observed in up to six percent of granulocytes, and the human granulocytic ehrlichiosis bacterium was cultured in an HL 60 human promyelocytic cell line. The patient improved dramatically within 24 hours of doxycycline treatment, after failing to improve on various beta lactam antimicrobial agents. He was discharged from the hospital 14 days after admission. Because human granulocytic ehrlichiosis was not diagnosed until his eight hospital day, clinical and laboratory parameters prior to specific treatment were available. This case illustrates the clinical and laboratory evolution of the infection with human granulocytic ehrlichiosis agent in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363404

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  1 in total

1.  In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.

Authors:  M Bayard-Mc Neeley; A Bansal; I Chowdhury; G Girao; C B Small; K Seiter; J Nelson; D Liveris; I Schwartz; D F Mc Neeley; G P Wormser; M E Aguero-Rosenfeld
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.